Cargando…
Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study
With the development of nanomedicine, more and more nanoparticles are used in the diagnosis and treatment of leukemia. This study aimed to identify author, country, institutional, and journal collaborations and their impacts, assess the knowledge base, identify existing trends, and uncover emerging...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588980/ https://www.ncbi.nlm.nih.gov/pubmed/36299285 http://dx.doi.org/10.3389/fbioe.2022.1027868 |
_version_ | 1784814196142112768 |
---|---|
author | Wang, Rui Zhao, Changming Jiang, Shuxia Zhang, Zhaohua Ban, Chunmei Zheng, Guiping Hou, Yan Jin, Bingjin Shi, Yannan Wu, Xin Zhao, Qiangqiang |
author_facet | Wang, Rui Zhao, Changming Jiang, Shuxia Zhang, Zhaohua Ban, Chunmei Zheng, Guiping Hou, Yan Jin, Bingjin Shi, Yannan Wu, Xin Zhao, Qiangqiang |
author_sort | Wang, Rui |
collection | PubMed |
description | With the development of nanomedicine, more and more nanoparticles are used in the diagnosis and treatment of leukemia. This study aimed to identify author, country, institutional, and journal collaborations and their impacts, assess the knowledge base, identify existing trends, and uncover emerging topics related to leukemia research. 1825 Articles and reviews were obtained from the WoSCC and analyzed by Citespace and Vosviewer. INTERNATIONAL JOURNAL OF NANOMEDICINE is the journal with the highest output. The contribution of FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY is also noteworthy. The three main aspects of research in Nanoparticles-leukemia-related fields included nanoparticles for the diagnosis and treatment of leukemia, related to the type and treatment of leukemia, the specific molecular mechanism, and existing problems of the application of nanoparticles in leukemia. In the future, synthesize nano-drugs that have targeted therapy and chemotherapy resistance according to the mechanism, which may be the dawn of the solution to leukemia. This study offers a comprehensive overview of the Nanoparticles-leukemia-related field using bibliometrics and visual methods for the first time, providing a valuable reference for researchers interested in Nanoparticles-leukemia. |
format | Online Article Text |
id | pubmed-9588980 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95889802022-10-25 Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study Wang, Rui Zhao, Changming Jiang, Shuxia Zhang, Zhaohua Ban, Chunmei Zheng, Guiping Hou, Yan Jin, Bingjin Shi, Yannan Wu, Xin Zhao, Qiangqiang Front Bioeng Biotechnol Bioengineering and Biotechnology With the development of nanomedicine, more and more nanoparticles are used in the diagnosis and treatment of leukemia. This study aimed to identify author, country, institutional, and journal collaborations and their impacts, assess the knowledge base, identify existing trends, and uncover emerging topics related to leukemia research. 1825 Articles and reviews were obtained from the WoSCC and analyzed by Citespace and Vosviewer. INTERNATIONAL JOURNAL OF NANOMEDICINE is the journal with the highest output. The contribution of FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY is also noteworthy. The three main aspects of research in Nanoparticles-leukemia-related fields included nanoparticles for the diagnosis and treatment of leukemia, related to the type and treatment of leukemia, the specific molecular mechanism, and existing problems of the application of nanoparticles in leukemia. In the future, synthesize nano-drugs that have targeted therapy and chemotherapy resistance according to the mechanism, which may be the dawn of the solution to leukemia. This study offers a comprehensive overview of the Nanoparticles-leukemia-related field using bibliometrics and visual methods for the first time, providing a valuable reference for researchers interested in Nanoparticles-leukemia. Frontiers Media S.A. 2022-10-10 /pmc/articles/PMC9588980/ /pubmed/36299285 http://dx.doi.org/10.3389/fbioe.2022.1027868 Text en Copyright © 2022 Wang, Zhao, Jiang, Zhang, Ban, Zheng, Hou, Jin, Shi, Wu and Zhao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Bioengineering and Biotechnology Wang, Rui Zhao, Changming Jiang, Shuxia Zhang, Zhaohua Ban, Chunmei Zheng, Guiping Hou, Yan Jin, Bingjin Shi, Yannan Wu, Xin Zhao, Qiangqiang Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study |
title | Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study |
title_full | Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study |
title_fullStr | Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study |
title_full_unstemmed | Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study |
title_short | Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study |
title_sort | advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: a bibliometrics study |
topic | Bioengineering and Biotechnology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588980/ https://www.ncbi.nlm.nih.gov/pubmed/36299285 http://dx.doi.org/10.3389/fbioe.2022.1027868 |
work_keys_str_mv | AT wangrui advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy AT zhaochangming advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy AT jiangshuxia advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy AT zhangzhaohua advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy AT banchunmei advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy AT zhengguiping advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy AT houyan advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy AT jinbingjin advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy AT shiyannan advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy AT wuxin advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy AT zhaoqiangqiang advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy |